Skip to main content

Table 1 Baseline characteristics of the patients

From: Lower versus higher hemoglobin threshold for transfusion in ARDS patients with and without ECMO

Characteristic

Higher-threshold group

(N = 96)

Lower-threshold group

(N = 96)

P value

SMD

Age (years)

52.0 (37.8–61.0)

51.0 (38.0–61.0)

0.85

0.040

Male sex, n (%)

59 (61.5)

68 (70.8)

0.22

0.199

Body mass index (kg/cm)

27.3 (24.1–31.2)

26.3 (23.4–29.7)

0.27

0.152

Charlson comorbidity index

2.0 (1.0–4.0)

2.0 (0.0–5.0)

0.99

0.076

Immunocompromised, n (%)

22 (22.9)

22 (22.9)

0.99

< 0.001

Year of admission, n (%)

  

< 0.001

1.830

 2007–2010

41 (42.7)

9 (9.4)

  

 2011–2014

46 (47.9)

14 (14.6)

  

 2015–2018

9 (9.4)

73 (76.0)

  

SOFA at ARDS onset

12.0 (9.0–15.0)

12.0 (9.0–16.0)

0.80

0.022

SAPS II at ARDS onset

57.5 (38.0–69.2)

57.0 (41.8–68.0)

0.74

0.030

RASS at ARDS onset

− 5.0 (− 5.0 to − 4.0)

− 5.0 (− 5.0 to − 4.4)

0.49

< 0.001

Chronic lung disease, n (%)

25 (26.0)

26 (27.1)

0.99

0.024

Pulmonary origin, n (%)

78 (81.2)

77 (80.2)

0.99

0.026

Mechanical ventilation before admission (days)

1.0 (0.5–6.5)

1.5 (1.0–5.8)

0.59

0.004

ARDS severity, n (%)

  

0.99

< 0.001

 Mild

0 (0)

0 (0)

  

 Moderate

10 (10.4)

10 (10.4)

  

 Severe

86 (89.6)

86 (89.6)

  

ARDS etiology, n (%)

  

0.67

0.228

 Pneumonia

64 (66.7)

57 (59.4)

  

 Aspiration

10 (10.4)

14 (14.6)

  

 Sepsis

7 (7.3)

6 (6.2)

  

 Pancreatitis

2 (2.1)

5 (5.2)

  

 Other

13 (13.5)

14 (14.6)

  

Rescue therapy

 Inhaled nitric oxide, n (%)

80 (83.3)

62 (64.6)

0.005

0.437

 Prone positioning, n (%)

72 (75.0)

67 (69.8)

0.52

0.117

Extracorporeal life support, n (%)

  

0.85

0.132

  No ECLS

33 (34.4)

37 (38.5)

  

  ECLA

9 (9.4)

6 (6.2)

  

  ECMO

50 (52.1)

49 (51.0)

  

  Combined

4 (4.2)

4 (4.2)

  

Ventilation parameters after initial optimization

 PaO2:FiO2 (mmHg)

129 (93–174)

130 (100–182)

0.65

0.050

 Oxygenation index

17.5 (12.5–26.3)

17.9 (11.6–26.2)

0.70

0.082

 PEEP (cm H2O)

16.0 (14.3–18.3)

18.0 (14.1–19.8)

0.23

0.035

 Driving pressure (cm H2O)

16.0 (12.9–19.2)

16.0 (13.2–18.1)

0.87

0.009

 Tidal volume (ml/kg PBW)

5.5 (3.8–7.1)

5.8 (4.1–6.9)

0.83

0.096

 Compliance (ml/cm H2O)

27 (19.0–36.4)

30 (20.7–38.2)

0.41

0.028

ECMO initiation (ICU day)

0 (0–0)

0 (0–0)

0.55

0.050

ECMO pump flow (l/min)

3.8 (3.0–4.3)

3.8 (3.2–4.2)

0.88

0.090

ECMO sweep gas flow (l/min)

4.0 (3.0–6.8)

4.0 (3.0–6.0)

0.44

0.156

Septic shock, n (%)

53 (55.2)

47 (50.5)

0.56

0.094

Lactate (mg/dl)

19.0 (13.0–43.5)

19.0 (11.8–56.8)

0.95

0.007

pH

7.3 (7.2–7.4)

7.3 (7.2–7.3)

0.98

0.019

RRT, n (%)

60 (62.5)

63 (65.6)

0.76

0.065

  1. Data are expressed as median [25%, 75% quartiles] or frequencies [%], as appropriate. P values were calculated using the exact Wilcoxon–Mann–Whitney test and the Fisher’s exact test, as appropriate. Standardized mean differences (SMD) are provided
  2. SOFA Sequential Organ Failure Assessment, SAPS Simplified Acute Physiology Score, RASS Richmond Agitation-Sedation Scale, ECLS extracorporeal life support, ECLA pumpless extracorporeal lung assist, ECMO extracorporeal membrane oxygenation, PEEP positive end-expiratory pressure, PBW predicted body weight, ICU intensive care unit, RRT renal replacement therapy